These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 2147211

  • 1. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
    Bagni B, Portaluppi F, Montanari L, Prandini N, Zatta G.
    J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
    Abdel-Dayem HM, Sadek S, al-Bahar R, Sabha M, el-Sayed M.
    Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
    [Abstract] [Full Text] [Related]

  • 3. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I, Stiglich F, Barbonetti C, Bonomo F, Maspero S, Paini S, Bottinelli G.
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [Abstract] [Full Text] [Related]

  • 4. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A, Eshima D, Fritzberg AR, Christian PE, Kasina S.
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [Abstract] [Full Text] [Related]

  • 5. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
    Russell CD, Dubovsky EV.
    J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
    [Abstract] [Full Text] [Related]

  • 6. 99mTc-MAG3: dynamic studies in patients with renal disease.
    Schaap GH, Alferink TH, de Jong RB, Oe PL, Roos JC, Donker AJ.
    Eur J Nucl Med; 1988 Jul; 14(1):28-31. PubMed ID: 2968259
    [Abstract] [Full Text] [Related]

  • 7. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A, Ziffer JA, Steves A, Eshima D, Delaney VB, Welchel JD.
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of 99mTc-MAG3 as a radiotracer to assess the function of transplanted kidney: comparison with 123I-OIH].
    Yamamoto K, Takahashi N, Sugimoto K, Yoshida M, Hayashi N, Ishii Y, Nishibuchi S, Muranaka K, Okada K, Miyazaki M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):409-13. PubMed ID: 7617467
    [Abstract] [Full Text] [Related]

  • 9. Prediction of renal transplant survival from early postoperative radioisotope studies.
    Russell CD, Yang H, Gaston RS, Hudson SL, Diethelm AG, Dubovsky EV.
    J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
    [Abstract] [Full Text] [Related]

  • 10. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U, Cordes M, Hosten N, Roll D, Hunger J, Felix R.
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [Abstract] [Full Text] [Related]

  • 11. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
    Taylor AT, Lipowska M, Hansen L, Malveaux E, Marzilli LG.
    J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
    [Abstract] [Full Text] [Related]

  • 12. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
    Rehling M, Nielsen BV, Pedersen EB, Nielsen LE, Hansen HE, Bacher T.
    Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
    [Abstract] [Full Text] [Related]

  • 13. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)].
    Ha-Kawa SK, Suga Y, Satou H, Tanaka Y.
    Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073
    [Abstract] [Full Text] [Related]

  • 14. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolçay S, Cansiz T, Kapicioğlu T, Urgancioğlu I.
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [Abstract] [Full Text] [Related]

  • 15. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U, Cordes M, Wilfling M, Hunger J, Hosten N, Gahl G.
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [Abstract] [Full Text] [Related]

  • 16. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
    Kengen RA, Meijer S, Beekhuis H, Piers DA.
    J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
    Shirakawa S, Tamaki N, Torizuka T, Fujita T, Yano S, Tsuchimochi S, Yonekura Y, Konishi J, Terai A.
    Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 123I-orthoiodohippurate.
    Itoh K, Tsukamoto E, Kakizaki H, Nonomura K, Furudate M.
    Nucl Med Commun; 1993 Aug; 14(8):644-52. PubMed ID: 8371889
    [Abstract] [Full Text] [Related]

  • 20. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L, Turoğlu HT, Onsel C, Ozker K, Uslu I, Atay S, Cansiz T, Sönmezoğlu K, Altiok E, Isitman AT.
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.